ACS chemical neuroscience molecule spotlight on BMS-708163

Research output: Contribution to journalReview article

5 Scopus citations

Abstract

BMS-708163 is a novel, sulfonamide containing γ-secretase inhibitor from Bristol-Myers Squibb Co. currently in Phase II clinical trials for the treatment of Alzheimer's disease (AD).

Original languageEnglish (US)
Pages (from-to)149-150
Number of pages2
JournalACS Chemical Neuroscience
Volume3
Issue number3
DOIs
Publication statusPublished - Mar 21 2012

    Fingerprint

Keywords

  • Alzheimer's disease
  • GSI
  • amyloid hypothesis
  • gamma-secretase inhibitors

ASJC Scopus subject areas

  • Biochemistry
  • Physiology
  • Cognitive Neuroscience
  • Cell Biology

Cite this